Actively Recruiting
Comparing Starting Blood Clot Prevention Before or After Liver Surgery A Randomized Study on Timing of Blood Thinner Use in Liver Resection
Led by Helsinki University Central Hospital · Updated on 2025-02-14
1012
Participants Needed
7
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to compare the timing of thromboprophylaxis in patients undergoing liver surgery, specifically liver resection, to prevent blood clots. There is currently no international agreement on whether to start thromboprophylaxis before or after surgery, and existing guidelines offer conflicting recommendations due to limited evidence. This study addresses this gap by conducting a prospective, randomized controlled trial to evaluate these two approaches. Participants are randomly assigned to receive thromboprophylaxis either before surgery or after surgery. The preoperative group will receive enoxaparin, tinzaparin, or dalteparin approximately 14 hours before the planned liver resection, with dosing adjusted based on kidney function. The postoperative group will not receive any thromboprophylaxis before surgery. The study is designed to monitor and compare outcomes related to clotting and bleeding events in these two groups. During the study, participants will be monitored for venous thromboembolisms within 30 days after liver resection, as well as other outcomes such as bleeding complications, postoperative complications, length of hospital stay, and blood transfusion requirements. Researchers will collect and analyze data on these measures to evaluate the safety and timing of thromboprophylaxis. The trial includes follow-up for 30 days post-surgery to assess these outcomes comprehensively.
CONDITIONS
Brief Title
Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
Research Team
V
Ville Sallinen, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here